Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: A Cohort Study
Authors:
- 1 June 2015
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 128 (6) , 653.e7-653.e16
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care & Research, 2012
- Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association With Improved SurvivalJournal of Cardiac Failure, 2012
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative dataPharmacoepidemiology and Drug Safety, 2012
- A combined comorbidity score predicted mortality in elderly patients better than existing scoresJournal of Clinical Epidemiology, 2011
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small SamplesAmerican Journal of Epidemiology, 2011
- Hyperuricemia and incident hypertension: A systematic review and meta‐analysisArthritis Care & Research, 2010
- Hyperuricemia and coronary heart disease: A systematic review and meta‐analysisArthritis Care & Research, 2010
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Hyperuricemia and risk of stroke: A systematic review and meta‐analysisArthritis Care & Research, 2009
- Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential HypertensionJAMA, 2008